Concept Life Sciences is a knowledge-based, science-led business providing a wide range of innovative and integrated solutions to clients in the pharmaceutical, biotechnology, agrochemical, petrochemical, chemical, cosmetics and consumer products sectors.
Concept was formed in 2014 following the merger of Scientific Analysis Laboratories (SAL), Agenda1 Analytical Services, Peakdale Molecular, CXR Biosciences and Resource & Environmental Consultants (REC).
Since then we have expanded through a mix of organic growth and targeted acquisition, most recently Aquila Biomedical in 2018. Today we are home to more than 250 employees, working from seven laboratories across the UK.
We have brought together teams of highly trained scientists, excellent laboratory facilities and an in-depth understanding of our core markets, and created a business that is greater than the sum of its parts.
Our teams share a common focus on problem solving, quality, collaboration, communication and flexibility and deliver a comprehensive platform of services in the Pharmaceutical and Crops & Chemicals sectors.
Concept Life Sciences is part of Spectris plc, the expert in providing insight through precision measurement. Spectris’ global group of businesses are focused on delivering value beyond measure for all our stakeholders. We target global, attractive and sustainable markets, where growth and high returns are supported by long-term drivers.
Precision is at the heart of what we do. We provide customers with expert insight through our advanced instruments and test equipment, augmented by the power of our software and services. This equips customers with the ability to reduce time to market, improve processes, quality and yield. In this way, Spectris know-how creates value for our wider society, as our customers design, develop, test and manufacture their products to make the world a cleaner, healthier and more productive place.
Spectris is headquartered in Egham, Surrey, United Kingdom, the Company employs approximately 9,000 people located in more than 30 countries. For more information visit, www.spectris.com